With a robust background in venture capital, the fund manager has successfully executed over 50 deals, primarily in the technology and healthcare sectors. Active across North America and Europe, the investment strategy emphasizes early to growth-stage companies, leveraging an operator-first approach to drive value creation. Noteworthy exits include several high-profile public offerings, showcasing a commitment to identifying and nurturing transformative innovations. The firm’s thematic focus aligns with emerging trends, ensuring a forward-looking portfolio that addresses critical market needs.